Catalog No.
PHE14401
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human CHOP/GADD153/DDIT3 (Arg105-Ala169).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, IF: 1:50-1:100, WB: 1:1000-1:4000
Target
C/EBP-homologous protein, DDIT3, DDIT-3, CCAAT/enhancer-binding protein homologous protein, C/EBP zeta, CHOP-10, Growth arrest and DNA damage-inducible protein GADD153, DNA damage-inducible transcript 3 protein, GADD153, CHOP10, C/EBP-homologous protein 10, CHOP
Purification
Purified by antigen affinity column.
Accession
P35638
Applications
ELISA, IHC, IF, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study., PMID:40532125
Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma., PMID:40530470
Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphoma., PMID:40528731
TNFα signaling restores steady-state hematopoiesis in a TNFαKO mouse model of anemia of inflammation., PMID:40512402
Utilization of anti-CD20 antibodies for treatment of childhood nephrotic syndrome, 2010 to 2022., PMID:40473981
Sarcopenia attenuates the efficacy of PEGylated granulocyte colony-stimulating factor in preventing febrile neutropenia., PMID:40464791
Treating newly diagnosed Diffuse Large B-cell Lymphoma in the elderly patient with R-mini-CHOP: A single centre analytical retrospective observational study., PMID:40437719
Toll-like receptor 9 (TLR9) expression correlates with cell of origin and predicts clinical outcome in diffuse large B-cell lymphoma., PMID:40437466
Management challenges of a rare case of the primary parotid gland non-Hodgkin lymphoma: A case report and review of the literature., PMID:40432560
Obinutuzumab-Induced Inflammatory Bowel Disease-Like Colitis., PMID:40421460
A Rare Case of Adrenal Intravascular Large B-Cell Lymphoma Diagnosed via Percutaneous Needle Biopsy., PMID:40410769
Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial., PMID:40397196
Report of Consensus Panel 6 from the 12th International Workshop on Waldenström's Macroglobulinemia on Diagnosis and Management of Transformed Waldenström's Macroglobulinemia., PMID:40382198
A phase 2 Trial of CHOP with Anti-CCR4 Antibody Mogamulizumab for older Patients with Adult T-Cell Leukemia/Lymphoma., PMID:40373281
An analysis of the relationship of triglyceride glucose index with diffuse large B-cell lymphoma prognosis: a retrospective study., PMID:40357210
Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients., PMID:40355770
Comparative effectiveness of different chemotherapies given to Nodular Lymphocyte Predominant Hodgkin Lymphoma patients: A retrospective study from Lahore, Pakistan., PMID:40344738
Upfront autologous hematopoietic stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma: A real-world multicenter study., PMID:40317151
Distinct Trajectories of Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Survivors Treated With R-CHOP., PMID:40293933
Tailored Therapeutic Approach in a Patient With Diffuse Large B-Cell Lymphoma With Meningeal Infiltration, Concurrent Classic Hodgkin Lymphoma, and Smoldering Multiple Myeloma: A Case Report., PMID:40232042
Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report., PMID:40230856
Clinical characteristics, treatment patterns and outcomes of patients with follicular lymphoma in Colombia: a real-world evidence cohort study., PMID:40227475
Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients., PMID:40204934
[Amyloid light-chain (AL) amyloidosis and follicular lymphoma: a case report]., PMID:40190438
Are oldest old patients with diffuse large B-cell lymphoma different than their younger counterparts: Results from the REALYSA real-life cohort., PMID:40188631
Phase I Study of Subcutaneous Rituximab Hyaluronidase Combined With CHOP Chemotherapy for the Treatment of Diffuse Large B-Cell Lymphoma in Uganda., PMID:40184567
Alternative regimen for chemotherapy-intolerant lymphoma including practical aspects in Japan., PMID:40176202
Central Nervous System Prophylaxis Approach in High-Risk Diffuse Large B-Cell Lymphoma Patients: A Retrospectively Collected, Single-Center Cohort Analysis., PMID:40166831
Poor outcome of older patients with diffuse large B-cell lymphoma after progression., PMID:40159282
[Long-term disease-free survival hepatic cavernous hemangioma with intravascular large B cell lymphoma: report of a case]., PMID:40159033
Zanubrutinib plus R-CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2., PMID:40145086
[Clinical study of orelabrutinib combined with R-CHOP regimen for newly diagnosed high-risk non-GCB diffuse large B-cell lymphoma with extranodal involvement]., PMID:40134200
Differences in Observed Outcomes and Toxicities for Adolescent and Young Adult Patients With Aggressive Mature B-Cell Lymphomas Treated at an Adult Versus Pediatric Cancer Center., PMID:40119760
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology., PMID:40112808
Complete response of unilateral primary lacrimal sac diffuse large B-cell lymphoma treated without radiotherapy in an adult: A rare case report and review of the literature., PMID:40112523
CYP3A5 Polymorphism in Circulating Tumor Cells Confers an Increased Disease-Free Survival in DLBCL Patients Treated with R-CHOP., PMID:40109410
Pediatric Vaccine-Induced Antibody Thresholds: Rethinking Pre-Immunosuppression Serologic Testing and Revaccination Implications., PMID:40105237
Temporal trends in time toxicity of R-CHOP: a nationwide hospital-based database analysis in Japan., PMID:40097772
CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery., PMID:40087866
Penile diffuse large B-cell lymphoma in a young man., PMID:40086840
Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study., PMID:40085955
Collision Tumor Consisting of Mantle Cell Lymphoma and Mucinous Adenocarcinoma in Ascending Colon: Case Report., PMID:40084711
C/EBP Homologous Protein Expression in Retinal Ganglion Cells Induces Neurodegeneration in Mice., PMID:40076484
Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study., PMID:40074837
A predictive model for identification of pediatric individuals with common variable immunodeficiency through electronic medical records., PMID:40058414
Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodies., PMID:40057826
18F-FDG PET/CT metabolic parameter changes to assess vascular inflammatory response in patients with diffuse large B-cell lymphoma., PMID:40055673
Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study., PMID:40037864
Using a Natural Triterpenoid to Unlock the Antitumor Effects of Autophagy in B-Cell Lymphoma., PMID:40002858
Overexpression of lncRNAs HOTAIR and MALAT1 While Downexpression of lncRNA PANDA Predict the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Chemoimmunotherapy., PMID:40001305
For research use only. Not for human or drug use.
